#14 How AI Cuts Trial Costs & Boosts Drug ROI. Vinodh Balaraman.
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
#14 How AI Cuts Trial Costs & Boosts Drug ROI. Vinodh Balaraman.
-
ナレーター：
-
著者：
概要
As part of the NYC Healthtech Social held on October 27, Vinodh Balaraman, a serial entrepreneur and Founder of Kolate AI, joined us for a fireside chat on how AI can improve clinical development and drug decision-making. Kolate AI is a precision medicine platform that predicts patient-level clinical events and therapy responses.
The conversation explores why nearly 90% of clinical development fails, how limited visibility into patient responses and enrollment contributes to those outcomes, and how Kolate AI supports pharma and biotech through patient-level prediction, synthetic control arms, and clinical trial screening. Vinodh also shares how these approaches can improve both trials and real-world drug use, and where regulators are beginning to engage with AI-driven methods.
Check out Kolate AI: www.kolate.ai